Author
Listed:
- Jinyan Liu
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Kara L. O’Brien
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Diana M. Lynch
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Nathaniel L. Simmons
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Annalena La Porte
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Ambryice M. Riggs
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Peter Abbink
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Rory T. Coffey
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Lauren E. Grandpre
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Michael S. Seaman
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
- Gary Landucci
(University of California, Irvine School of Medicine, Irvine, California 92697, USA)
- Donald N. Forthal
(University of California, Irvine School of Medicine, Irvine, California 92697, USA)
- David C. Montefiori
(Duke University Medical Center, Durham, North Carolina 27710, USA)
- Angela Carville
(New England Primate Research Center, Southborough, Massachusetts 01772, USA)
- Keith G. Mansfield
(New England Primate Research Center, Southborough, Massachusetts 01772, USA)
- Menzo J. Havenga
(TNO Biosciences, 2301 CE, Leiden, The Netherlands)
- Maria G. Pau
(Crucell Holland BV, 2301 CA, Leiden, The Netherlands)
- Jaap Goudsmit
(Crucell Holland BV, 2301 CA, Leiden, The Netherlands)
- Dan H. Barouch
(Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA)
Abstract
AIDS vaccine rethink Recent setbacks have prompted a major re-evaluation of the AIDS vaccine field. One question that has been asked is whether to continue development of T-cell-based HIV-1 vaccines. Now a study of a new vaccine in monkeys challenged with simian immunodeficiency virus (SIV) suggests that the T-cell-based strategy remains potentially viable. The vaccine was prepared using two adenovirus vectors (rAd26 prime/rAd5 boost) expressing SIV Gag protein. It induced potent T-cell immune responses and some protection from infection. These findings provide pointers to the design of a new generation of T-cell-based vaccine candidates for HIV-1.
Suggested Citation
Jinyan Liu & Kara L. O’Brien & Diana M. Lynch & Nathaniel L. Simmons & Annalena La Porte & Ambryice M. Riggs & Peter Abbink & Rory T. Coffey & Lauren E. Grandpre & Michael S. Seaman & Gary Landucci & , 2009.
"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys,"
Nature, Nature, vol. 457(7225), pages 87-91, January.
Handle:
RePEc:nat:nature:v:457:y:2009:i:7225:d:10.1038_nature07469
DOI: 10.1038/nature07469
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:457:y:2009:i:7225:d:10.1038_nature07469. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.